Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1988 Oct;41(10):1130–1134. doi: 10.1136/jcp.41.10.1130

An ELISA to detect antipseudomonal IgA antibodies in sera of patients with cystic fibrosis.

M M Brett 1, A T Ghoneim 1, J M Littlewood 1
PMCID: PMC1141703  PMID: 3142934

Abstract

An enzyme linked immunosorbent assay (ELISA) to measure free serum IgA antibodies to Pseudomonas aeruginosa in patients with cystic fibrosis is described. Results were reproducible and there was no interference from crossreacting antibodies directed against other Gram negative bacteria. Titres were high in patients with Pseudomonas aeruginosa infection and differed according to the stage of the infection. These preliminary results suggest that this assay may be of value in assessing the state of Pseudomonas aeruginosa infection in patients with cystic fibrosis.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blackshaw A. J., Levison D. A. Eosinophilic infiltrates of the gastrointestinal tract. J Clin Pathol. 1986 Jan;39(1):1–7. doi: 10.1136/jcp.39.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brett M. M., Ghoneim A. T., Littlewood J. M. Serum IgG antibodies in patients with cystic fibrosis with early Pseudomonas aeruginosa infection. Arch Dis Child. 1987 Apr;62(4):357–361. doi: 10.1136/adc.62.4.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Butler J. E., Feldbush T. L., McGivern P. L., Stewart N. The enzyme-linked immunosorbent assay (ELISA): a measure of antibody concentration or affinity. Immunochemistry. 1978 Feb;15(2):131–136. doi: 10.1016/0161-5890(78)90053-6. [DOI] [PubMed] [Google Scholar]
  4. Cost K. M., West C. S., Brinson D., Polk H. C., Jr Measurement of human antibody activity against Escherichia coli and Pseudomonas aeruginosa using formalin treated whole organisms in an ELISA technique. J Immunoassay. 1985;6(1-2):23–43. doi: 10.1080/01971528508063019. [DOI] [PubMed] [Google Scholar]
  5. GIBSON L. E., COOKE R. E. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics. 1959 Mar;23(3):545–549. [PubMed] [Google Scholar]
  6. Hollsing A. E., Granström M., Vasil M. L., Wretlind B., Strandvik B. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis. J Clin Microbiol. 1987 Oct;25(10):1868–1874. doi: 10.1128/jcm.25.10.1868-1874.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kaltreider H. B. Expression of immune mechanisms in the lung. Am Rev Respir Dis. 1976 Mar;113(3):347–379. doi: 10.1164/arrd.1976.113.3.347. [DOI] [PubMed] [Google Scholar]
  8. Kohler R. B., Wheat L. J., White A. Rapid diagnosis of Pseudomonas aeruginosa urinary tract infections by radioimmunoassay. J Clin Microbiol. 1979 Feb;9(2):253–258. doi: 10.1128/jcm.9.2.253-258.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mearns M. B., Hunt G. H., Rushworth R. Bacterial flora of respiratory tract in patients with cystic fibrosis, 1950-71. Arch Dis Child. 1972 Dec;47(256):902–907. doi: 10.1136/adc.47.256.902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pier G. B. Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction. J Infect Dis. 1985 Apr;151(4):575–580. doi: 10.1093/infdis/151.4.575. [DOI] [PubMed] [Google Scholar]
  11. Quie P. G. Lung defense against infection. J Pediatr. 1986 May;108(5 Pt 2):813–816. doi: 10.1016/s0022-3476(86)80750-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES